IC
AEMD icon

Ikarian Capital’s Aethlon Medical AEMD Stock Holding History

Ikarian Capital’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
2,873
– – ﹤0.01% 154
2026
Q1 		$31.5K Hold
2,873
– – ﹤0.01% 157
2025
Q4 		$39.8K Sell
2,873
-200
-7% -$4.65K ﹤0.01% 167
2025
Q3 		$115K Hold
3,073
– – 0.01% 162
2025
Q2 		$184K Hold
3,073
– – 0.04% 115
2025
Q1 		$440K Buy
3,073
+1,198
+64% +$279K 0.05% 120
2024
Q4 		$645K Buy
+1,875
New +$318K 0.09% 124

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ikarian Capital's AEMD Position: Q2 2026 in Review

Ikarian Capital held its Aethlon Medical (AEMD) position steady in Q2 2026 at 2,873 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #154.

Ikarian Capital first reported a position in AEMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $645K in Q4 2024. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Ikarian Capital held 2,873 shares of Aethlon Medical worth $11.8K as of Q2 2026.
  • Ikarian Capital left its Aethlon Medical share count unchanged in Q2 2026.
  • Aethlon Medical made up ﹤0.01% of Ikarian Capital's portfolio in Q2 2026, its #154 holding.
  • Ikarian Capital first reported a position in Aethlon Medical in Q4 2024 and has held it in 7 quarters since.
  • Ikarian Capital's Aethlon Medical position peaked at $645K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.